Target intelligence / Profile preview

RNA, U6 small nuclear 422, pseudogene (RNU6-422P)

Target
RNU6-422P
Molecular classification
Other (Pseudogene, non-coding RNA pseudogene)
01

Overview

RNU6-422P is a pseudogene related to the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a highly conserved non-coding RNA essential for pre-mRNA splicing as a core component of the spliceosome in eukaryotic cells[1][3]. However, RNU6-422P itself is a duplicated or processed, non-functional sequence that does not produce functionally active RNA or protein and does not participate in splicing or any other defined biological process[2]. Pseudogenes like RNU6-422P are generally considered "genomic fossils"; they might retain some regulatory or transcriptional signatures, but are not considered functional targets for drug discovery, diagnostics, or therapeutic modulation[2]. There is no evidence that RNU6-422P is involved in disease, nor is it established as a biomarker or a molecule with therapeutic relevance. Context for Parent Molecule: The functional U6 small nuclear RNA (U6 snRNA) is critical for spliceosome function and pre-mRNA splicing in the nucleus[1][3]. While pseudogenes may occasionally have residual or regulatory effects, there is no current evidence that RNU6-422P possesses any such activity in humans[2]. Notes: - is_incorrect: true — Although the name refers to a real genomic locus, RNU6-422P is not a functional molecular target, but rather a pseudogene. The entry is correct in nomenclature but incorrect as a meaningful molecular or therapeutic target. - In vertebrates, including humans, multiple U6 pseudogenes exist; they are widespread and not considered druggable or relevant in clinical research[3]. - Structured information systems should not catalogue RNU6-422P as a legitimate disease or drug target; it should only be indexed as a non-functional pseudogene[2].

Other names
RNU6-422PU6 snRNA pseudogeneU6 small nuclear RNA pseudogene
02

Mechanism of action

None

03

Biological functions

None
04

Disease associations

None established
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U6 small nuclear 422, pseudogene (RNU6-422P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 422, pseudogene (RNU6-422P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call